Biomarin Pharmaceutical Inc
2013 Q4 - 2025 Q4 (28 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 1/27/2026 | 3,649 | 0.0% | 61,400 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 8,712 | 0.0% | 160,851 | 9/30/2025 |
| 2025 Q2 | 8/7/2025 | 11,916 | 0.0% | 216,780 | 6/30/2025 |
| 2025 Q1 | 5/7/2025 | 14,736 | 0.0% | 208,455 | 3/31/2025 |
| 2024 Q4 | 2/7/2025 | 13,064 | 0.0% | 198,756 | 12/31/2024 |
| 2024 Q3 | 11/14/2024 | 6,815 | 0.0% | 96,962 | 9/30/2024 |
| 2024 Q2 | 7/29/2024 | 7,770 | 0.0% | 94,374 | 6/30/2024 |
| 2024 Q1 | 4/25/2024 | 8,087 | 0.0% | 92,596 | 3/31/2024 |
| 2023 Q4 | 1/30/2024 | 7,531 | 0.0% | 78,110 | 12/31/2023 |
| 2023 Q3 | 10/25/2023 | 3,173 | 0.0% | 35,860 | 9/30/2023 |
| 2023 Q2 | 8/7/2023 | 3,157 | 0.0% | 36,416 | 6/30/2023 |
| 2023 Q1 | 5/8/2023 | 3,233 | 0.0% | 33,245 | 3/31/2023 |
| 2022 Q4 | 2/1/2023 | 3,447 | 0.0% | 33,306 | 12/31/2022 |
| 2022 Q3 | 11/9/2022 | 2,862 | 0.0% | 33,765 | 9/30/2022 |
| 2022 Q2 | 8/9/2022 | 2,466 | 0.0% | 29,753 | 6/30/2022 |
| 2022 Q1 | 4/21/2022 | 2,403 | 0.0% | 31,165 | 3/31/2022 |
| 2021 Q4 | 2/1/2022 | 2,597 | 0.0% | 29,394 | 12/31/2021 |
| 2021 Q3 | 11/15/2021 | 3,411 | 0.0% | 44,127 | 9/30/2021 |
| 2021 Q2 | 7/30/2021 | 3,833 | 0.0% | 45,938 | 6/30/2021 |
| 2021 Q1 | 5/3/2021 | 3,450 | 0.0% | 45,687 | 3/31/2021 |
| 2020 Q4 | 1/28/2021 | 3,362 | 0.0% | 38,341 | 12/31/2020 |
| 2020 Q3 | 11/6/2020 | 2,843 | 0.0% | 37,368 | 9/30/2020 |
| 2020 Q2 | 7/28/2020 | 3,579 | 0.0% | 29,021 | 6/30/2020 |
| 2020 Q1 | 5/6/2020 | 3,170 | 0.0% | 37,513 | 3/31/2020 |
| 2019 Q4 | 1/21/2020 | 2,948 | 0.0% | 34,864 | 12/31/2019 |
| 2014 Q2 | 8/6/2014 | 3,699 | 0.1% | 59,456 | 6/30/2014 |
| 2014 Q1 | 4/29/2014 | 2,613 | 0.1% | 38,310 | 3/31/2014 |
| 2013 Q4 | 2/3/2014 | 3,685 | 0.1% | 52,446 | 12/31/2013 |